FRONT, ALGO and PRE rallied in excess of 40% as altcoins capitalize on Bitcoin’s range-bound price action.

Market Update, CryptoMarket, Markets Pro, Markets, Presearch, Algorand, Proof-of-Stake, Frontier, DeFiRead More

You might also be interested in reading Genmab reportedly nearing deal to acquire cancer drug developer Merus.